Arias RGA, Delgado SVF, Navas CMG

Language: Spanish
References: 17
Page:
PDF size: 167.56 Kb.

ABSTRACT

Blood transfusions are procedures performed daily in healthcare centers around the world, and acute transfusion reactions are a serious and potentially life-threatening complication associated with them. Acute transfusion reactions are defined as those that occur within the first 24 hours, with the most frequent being non-hemolytic febrile reactions, allergic and anaphylactic reactions, circulatory overload, acute lung injury, and hemolysis. Clinical manifestations range from very mild and self-limiting, such as fever, chills, nausea, and changes in blood pressure and heart rate, to more serious ones with cardiovascular compromise, renal failure, coagulation disorders, and even death.
Understanding the pathophysiology, risk factors, and differences in clinical presentation allows for early identification of the reaction, which is critical to minimizing morbidity and mortality and optimizing clinical outcomes. The implementation of mitigation strategies and other preventive measures can reduce the risk of adverse events related to transfusion. Measures such as appropriate donor selection, accurate recipient identification, and continuous monitoring in patients with risk factors such as children, older adults, patients with cardiac or renal problems, a history of cancer, or repeat transfusions. This article reviews the current literature on acute transfusion reactions and provides useful information for clinical practice.

REFERENCES

1. Abdallah R, Rai H, Panch SR. Transfusion Reactions and Adverse Events. Clin Lab Med. Bethesda [Internet]. 2021 [citado el 08 Mar 2023] 41:669–96. Disponible en: https://doi.org/10.1016/j.cll.2021.07.009

2. Raval JS, Griggs JR, Fleg A. Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications. Am Fam Physician [Internet]. 01 Jun 2020 [citado el 08 Mar 2023];102(1):30–8. Disponible en: https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2020/0701/p30.pdf

3. Goel R, Tobian AAR, Shaz BH. Noninfectious transfusion-associated adverse events and their mitigation strategies. Blood New York [Internet]. Abr, 2019 [citado el 09 Mar 2023];133. Disponible en: https://doi.org/10.1182/blood-2018-10-833988

4. Garraud O, Cognasse F, Laradi S, Hamzeh-Cognasse H, Peyrard T, Tissot JD, et al. How to mitigate the risk of inducing transfusion-associated adverse reactions. Transfusion Clinique et Biologique. Elsevier Masson SAS [Internet]. 2018 [citado el 09 Mar 2023];25:262–8. Disponible en: https://doi.org/10.1016/j.tracli.2018.07.006

5. Mowla SJ, Sapiano MRP, Jones JM, Berger JJ, Basavaraju S V. Supplemental findings of the 2019 National Blood Collection and Utilization Survey. Transfusion (Paris) [Internet]. 01 Sep 2021 [citado el Mar 26, 2023];61(2):S11–35. Disponible en: https://doi.org/10.1111%2Ftrf.16606

6. Sostin N, Hendrickson JE. Pediatric Hemovigilance and Adverse Transfusion Reactions. Clin Lab Med [Internet]. 2021 [citado el 11 Mar 2023];41:51–67. Disponible en: https://doi.org/10.1016/j.cll.2020.10.004

7. Guadalupe Bravo-Lindoro A. Efectos adversos inmediatos de la transfusión en niños. Rev Hematol Mex [Internet]. Ene 2020 [citado el 11 de marzo, 2023];21(1):1–7. Disponible en: https://doi.org/10.24245/rev_hematol.v21i1.3891

8. Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood [Internet]. Abr 2019 [citado el 10 Mar 2023];133. Disponible en: https://doi.org/10.1182/blood-2018-10-860809

9. Van den Akker TA, Grimes ZM, Friedman MT. Transfusion-Associated Circulatory Overload and Transfusion-Related Acute Lung Injury Am J Clin Pathol. Oxford University Press [Internet]. 2021 [citado el 15 Mar2023];156:529-39. Disponible en: https://doi.org/10.1093/ajcp/aqac127

10. Klanderman RB, Bosboom JJ, Migdady Y, Veelo DP, Geerts BF, Murphy MF, et al. Transfusion-associated circulatory overload—a systematic review of diagnostic biomarkers. Transfusion [Internet]. 2019 [citado el 15 Mar 2023];59:765-805. Disponible en: https://doi.org/10.1111/trf.15068

11. Panch SR, Montemayor-Garcia C, Klein HG. Hemolytic Transfusion Reactions. Longo DL, editor. N Engl J Med [Internet]. Jul 11, 2019 [citado el 09 Mar 2023];381(2):150-62. Disponible en: http://www.nejm.org/doi/10.1056/NEJMra1802338

12. Gehrie EA, Savani BN, Booth GS. Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease. Blood Reviews. Churchill Livingstone [Internet]. 2021 [citado el 12 Mar 2023];45. Disponible en: https://doi.org/10.1016/j.blre.2020.100719

13. Zulkeflee RH, Hassan MN, Hassan R, Saidin NIS, Zulkafli Z, Ramli M, et al. Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports. Transfusion and Apheresis Science [Internet]. 30 Ene 2023 [citado el 11 Mar 2023]. Disponible en: https://doi.org/10.1016/j.transci.2023.103658

14. Soler Noda G, Fernández Delgado ND. Eventos adversos en la práctica transfusional: reacción transfusional hemolítica inmune. Rev Cubana Hematol Inmunol Hemoter [Internet]. Feb 2022 [citado el 11 de marzo, 2023]. Disponible a partir de: https://revhematologia.sld.cu/index.php/hih/article/view/1499

15. Arthur CM, Chonat S, Fasano R, Yee MEM, Josephson CD, Roback JD, et al. Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions. Transfusion Medicine Reviews. W.B. Saunders [Internet]. 2019 [citado el 11 Mar 2023];33:217–24. Disponible en: https://doi.org/10.1016/j.tmrv.2019.09.006

16. Deveci B, Saba R, Altunay H, Toptas T, Kublashvilli G, Karadogan I. Severe Acute Hemolytic Transfusion Reaction Treated with Ruxolitinib and Plasma Exchange. Transfus Med Hemother [Internet]. 08 Ene 2021 [citado el 12 Mar 2023];48(4):250–2. Disponible en: https://doi.org/10.1159/000513056

17. Carvajal Gutiérrez V, Contreras Carmona P, Molina Ulloa S. Lineamiento para la Selección de Donantes de Sangre. CCSS [Internet]. 2018 [citado el 15 de marzo, 2023]. Disponible a partir de: https://www.cendeisss.sa.cr/wp/wp-content/uploads/2022/03/Lineamiento-para-la-Seleccion-de-Donantes-de-Sangre.-Version-2.-CCSS.-Mayo-2018.pdf